ストックスクリーナーアプリを入手
528.79
0.76%
-4.07
アフターアワーズ：
528.79
Idexx Laboratories Inc (IDXX) 最新ニュース
IDEXX Laboratories stock (US45167R1041): Diagnostics demand keeps investors focused - AD HOC NEWS
IDXX Technical Analysis & Stock Price Forecast - Intellectia AI
Northwestern Mutual Wealth Management Co. Increases Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Idexx Laboratories Shareholders Approve Governance and Meeting Reforms - TipRanks
IDEXX Laboratories stock (US45168D1046): Q1 2025 earnings highlight growth in pet diagnostics - AD HOC NEWS
IDEXX (NASDAQ: IDXX) declassifies board, grants 25% special-meeting right - Stock Titan
Capitalizing On Growth Prospects, Irene Chang Britt Acquires IDEXX Laboratories Stock Options Worth $771 - Benzinga
Bruce L Claflin Backs Up Beliefs With A Notable Acquisition Of IDEXX Laboratories Stock Options Worth $77 - Benzinga
In A Strategic Move, Joseph L Hooley Acquires IDEXX Laboratories Stock Options Worth $771: Enhancing Valu - Benzinga
Karen Peacock At IDEXX Laboratories Exercises Options Worth $0 - Benzinga
Engaging In Insider Activity, Sam Samad At IDEXX Laboratories Exercises Options Worth $0 - Benzinga
IDEXX announces UK availability of cancer Dx panel for early detection of canine lymphoma - MSN
IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day - 01net
IDEXX (IDXX) director Vandebroek receives RSU and option grants as compensation - Stock Titan
Director Sam Samad (NASDAQ: IDXX) receives new stock units and options grant - Stock Titan
IDEXX (IDXX) director granted stock options and deferred stock units - Stock Titan
IDEXX (IDXX) director Lawrence Kingsley awarded RSUs and stock options - Stock Titan
IDEXX (IDXX) grants director RSUs and stock options at $533.92 - Stock Titan
IDEXX (NASDAQ: IDXX) director Hooley granted deferred units and options - Stock Titan
IDEXX (IDXX) director Stuart Essig granted RSUs and options in new equity awards - Stock Titan
IDEXX (NASDAQ: IDXX) director Bruce Claflin granted deferred stock units and options - Stock Titan
IDEXX (IDXX) director receives new stock options and deferred units - Stock Titan
Do You Believe in the Long-Term Growth Potential of IDEXX Laboratories (IDXX)? - Insider Monkey
IDEXX Laboratories stock (US45167R1041): Q1 earnings beat with 14.3% revenue growth - AD HOC NEWS
IDEXX Laboratories, Inc. Stock 12‑Month Price Target Cut to $714.36, Implies 35% Upside - TradingView
HARVEY INVESTMENT CO LLC's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
TCW Concentrated Large Cap Growth Fund's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
IDXX Technical Analysis | Trend, Signals & Chart Patterns | IDEXX LABORATORIES INC (NASDAQ:IDXX) - ChartMill
IDEXX Laboratories, Inc. Stock 12‑Month Price Target Cut to $721.5, Implies 35% Upside - TradingView
IDEXX Laboratories Inc (IDXX) Stock Down 4.7% -- Now Undervalued? GF Score: 98/100 - GuruFocus
IDEXX Laboratories stock (US45167R1041): Shares fall 5% despite beating earnings estimates - AD HOC NEWS
IDEXX Laboratories Inc (IDXX) Shares Fall 5.0% -- What GF Score of 99 Tells Investors - GuruFocus
IDEXX (IDXX) director’s RSUs vest into 257 shares, holdings updated - Stock Titan
IDEXX (IDXX) director Szostak adds 257 shares as RSUs vest into stock - Stock Titan
IDEXX (IDXX) director Karen Peacock converts 101 RSUs into 102-share holding - Stock Titan
Director at IDEXX Laboratories (IDXX) gains 339 shares from RSU vesting - Stock Titan
IDEXX Laboratories (NASDAQ: IDXX) director gains 257 shares from RSU vesting - Stock Titan
Director Hooley of IDEXX (NASDAQ: IDXX) gains 158 common shares via RSU vesting - Stock Titan
IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors - MarketWatch
BofA Sees Slower InVue Installations as Headwind for IDEXX Laboratories, Inc. (IDXX) - Insider Monkey
IDEXX Laboratories Drops 5.8% Amid Sector-Wide Selling - AlphaStreet
What you need to know ahead of IDEXX Laboratories' earnings release - MSN
IDEXX Laboratories stock (US45168D1046): Mixed price moves amid strong earnings and valuation debate - AD HOC NEWS
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
Here’s Why IDEXX Laboratories Stock Could Deliver Around 11% Annual Returns Despite a 15% YTD Pullback - TIKR.com
Truist Financial Corp Sells 1,993 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Analyst Estimates: Here's What Brokers Think Of IDEXX Laboratories, Inc. (NASDAQ:IDXX) After Its First-Quarter Report - Yahoo Finance
Companion Animal Diagnostics Market Valued at USD 7.6 Billion - openPR.com
Jefferies Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $729 - Moomoo
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $675 - 富途牛牛
Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $805 - Moomoo
IDEXX Laboratories Q1 2026 earnings preview - MSN
Transcript: IDEXX Laboratories Q1 2026 Earnings Conference Call - Sahm
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2026 Earnings Call Transcript - Insider Monkey
Jefferies Adjusts Price Target on IDEXX Laboratories to $792 From $785 - marketscreener.com
IDEXX Laboratories Lifts Guidance on Robust Q1 - TipRanks
IDEXX Laboratories Inc | 10-Q: Q1 2026 Earnings Report - Moomoo
BofA cuts Idexx Laboratories stock price target on macro concerns By Investing.com - Investing.com South Africa
IDEXX (NASDAQ: IDXX) lifts Q1 profit and ramps up buybacks - Stock Titan
BofA cuts Idexx Laboratories stock price target on macro concerns - Investing.com
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $660 - 富途牛牛
Idexx Earnings: Strong Quarterly Results Lead to a More Optimistic Outlook From Management - Morningstar
IDEXX Laboratories Q1 Earnings Call Highlights - Yahoo Finance
1.20%
大文字化:
|
ボリューム (24 時間):